📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.00
SENTIMENT
BULLISH
TOTAL VIEWS
1
2-DAY GRADE TIMELINE
2026-06-12
TODAY
RECENT COVERAGE · 5 ARTICLES
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
Zealand Pharma disclosed routine share repurchase activity during week 26 of 2026 as part of an authorized buyback program. This...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Zealand Pharma (ZEAL) has disclosed insider trading activity involving managerial officers and closely associated persons, a routine...
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
Zealand Pharma disclosed routine share repurchase activity during week 25 of 2026 as part of an ongoing buyback authorization. This...
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
Zealand Pharma has disclosed routine share repurchase activity for week 24 of 2026 under its authorized buy-back program. This...
Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data
Eli Lilly (LLY) and peer biotech firms secured FDA approvals across oncology, dermatology, and rare disease indications this week,...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice